ATNF
Closed
180 Life Sciences Corp
0.89
-0.04 (-4.31%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.9282
Day's Range: 0.89 - 0.9449
Send
sign up or login to leave a comment!
When Written:
1.7499
180 Life Sciences Corp is a clinical-stage biotechnology company that is focused on developing novel therapies for the treatment of inflammatory and fibrotic diseases. The company's lead drug candidate, known as Anti-TNF, is a potential treatment for chronic inflammation and pain associated with osteoarthritis.
The company was founded in 2020 and is headquartered in the United Kingdom. Its management team includes experienced executives from the biotechnology and pharmaceutical industries, as well as leading academic researchers in the fields of inflammation and fibrosis.
180 Life Sciences Corp is publicly traded on the NASDAQ under the ticker symbol ATNF.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The company was founded in 2020 and is headquartered in the United Kingdom. Its management team includes experienced executives from the biotechnology and pharmaceutical industries, as well as leading academic researchers in the fields of inflammation and fibrosis.
180 Life Sciences Corp is publicly traded on the NASDAQ under the ticker symbol ATNF.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








